Last reviewed · How we verify
non-target drug — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
non-target drug (non-target drug) — OmicsWay Corp..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| non-target drug TARGET | non-target drug | OmicsWay Corp. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- non-target drug CI watch — RSS
- non-target drug CI watch — Atom
- non-target drug CI watch — JSON
- non-target drug alone — RSS
Cite this brief
Drug Landscape (2026). non-target drug — Competitive Intelligence Brief. https://druglandscape.com/ci/non-target-drug. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab